Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials

By sjmartinez • July 23, 2024

Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials. JAMA. 2024 Jul 22. doi: 10.1001/jama.2024.12414. Epub ahead of print. PMID: 39037800.

Tags: Digestive Diseases, Publications

Comparative evaluation of bipolar versus monopolar energy platforms in G-POEM for gastroparesis: technical performance, learning curves, and clinical outcomes

Sarici IS, Khataniar H, Kolb JM, Eriksson SE, Newhams K, Albus K, Zheng P, Ayazi S. Comparative evaluation of bipolar versus monopolar energy platforms in[...]

Factors Associated With Food Allergy and Gut Microbiota Dysfunction

McCarthy WJ, Ferguson F, Jacobs JP. Factors Associated With Food Allergy and Gut Microbiota Dysfunction. JAMA Pediatr. 2026 Jun 8. doi: 10.1001/jamapediatrics.2026.2034. Epub ahead of[...]

Social determinants of health and sex differences: insights from NIH Specialized Centers of Research Excellence (SCORE)

A McKee S, Chang L, M Aris I. Social determinants of health and sex differences: insights from NIH Specialized Centers of Research Excellence (SCORE). Biol[...]